FALSE CLAIMS ACT SUIT ALLEGING BOGUS DEMENTIA DRUG PATENTS BARRED

摘要

A patent attorney cannot pursue a False Claims Act suit alleging Allergan Inc. and Adamas Pharma LLC overcharged Medicare and Medicaid for two dementia drugs after fraudulently obtaining patents to block generic competition, a San Francisco magistrate judge has ruled.